As of 2025-07-21, the Relative Valuation of ST Pharm Co Ltd (237690.KQ) is 47,422.32 KRW. This relative valuation is based on P/E multiples. With the latest stock price at 88,900.00 KRW, the upside of ST Pharm Co Ltd based on Relative Valuation is -46.7%.
The range of the Relative Valuation is 32,612.61 - 68,267.25 KRW.
| Range | Selected | |
| Trailing P/E multiples | 22.3x - 34.6x | 28.8x |
| Forward P/E multiples | 15.3x - 28.8x | 22.2x |
| Fair Price | 32,612.61 - 68,267.25 | 47,422.32 |
| Upside | -63.3% - -23.2% | -46.7% |
| Date | P/E |
| 2025-07-18 | 64.09 |
| 2025-07-17 | 60.68 |
| 2025-07-16 | 60.00 |
| 2025-07-15 | 58.63 |
| 2025-07-14 | 57.61 |
| 2025-07-11 | 56.86 |
| 2025-07-10 | 58.43 |
| 2025-07-09 | 56.31 |
| 2025-07-08 | 57.13 |
| 2025-07-07 | 57.33 |
| 2025-07-04 | 57.88 |
| 2025-07-03 | 60.07 |
| 2025-07-02 | 58.84 |
| 2025-07-01 | 57.61 |
| 2025-06-30 | 52.56 |
| 2025-06-27 | 52.22 |
| 2025-06-26 | 53.03 |
| 2025-06-25 | 54.06 |
| 2025-06-24 | 53.99 |
| 2025-06-23 | 53.44 |
| 2025-06-20 | 55.15 |
| 2025-06-19 | 52.76 |
| 2025-06-18 | 53.24 |
| 2025-06-17 | 53.99 |
| 2025-06-16 | 54.54 |
| 2025-06-13 | 55.42 |
| 2025-06-12 | 56.65 |
| 2025-06-11 | 57.13 |
| 2025-06-10 | 56.79 |
| 2025-06-09 | 54.81 |
| 2025-06-05 | 52.69 |
| 2025-06-04 | 53.38 |
| 2025-06-02 | 54.26 |
| 2025-05-30 | 54.06 |
| 2025-05-29 | 52.90 |
| 2025-05-28 | 52.15 |
| 2025-05-27 | 52.90 |
| 2025-05-26 | 52.28 |
| 2025-05-23 | 51.53 |
| 2025-05-22 | 51.60 |
| 2025-05-21 | 51.67 |
| 2025-05-20 | 50.44 |
| 2025-05-19 | 48.87 |
| 2025-05-16 | 49.69 |
| 2025-05-15 | 50.92 |
| 2025-05-14 | 50.65 |
| 2025-05-13 | 50.24 |
| 2025-05-12 | 48.94 |
| 2025-05-09 | 50.92 |
| 2025-05-08 | 51.53 |